Seegene, Inc. is a healthcare company based in South Korea with an ESG score of 25.9, indicating a medium risk assessment. Specializing in advanced technology for precise disease diagnosis, Seegene's products focus on pathogen inspection solutions for respiratory, gastrointestinal, tuberculosis, and meningitis pathogens.